NCT05688215
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma
- Locations
-
- Yonemoto,Lisa Los Angeles, California, United States
Clinical trial condition
Locally Advanced Pancreatic Ductal Adenocarcinoma
Explore clinical trials studying Locally Advanced Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
13 public trials
8 recruiting studies
Locally Advanced Pancreatic Ductal Adenocarcinoma trial results
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- City of Hope Duarte, California, United States
- CIty of Hope Irvine, California, United States
- Christus St. Vincent Regional Cancer Center Santa Fe, New Mexico, United States
- Oncology Consultants, P.A. Houston, Texas, United States
Recruiting
OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
NCT07089940
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT04005690
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +13 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Recruiting
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
NCT06574620
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, +1 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
NCT07269626
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
- Samsung Medical Center Seoul, Select Province/State, South Korea
NCT06600906
- Conditions
- Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT07101679
- Conditions
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
Not Yet Recruiting
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
NCT07645651
- Conditions
- Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT04106856
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States